136 related articles for article (PubMed ID: 18045611)
1. Identification of prostate cancer antigens by automated high-throughput filter immunoscreening.
Alsøe L; Stacy JE; Fosså A; Funderud S; Brekke OH; Gaudernack G
J Immunol Methods; 2008 Jan; 330(1-2):12-23. PubMed ID: 18045611
[TBL] [Abstract][Full Text] [Related]
2. Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display.
Fosså A; Alsøe L; Crameri R; Funderud S; Gaudernack G; Smeland EB
Cancer Immunol Immunother; 2004 May; 53(5):431-8. PubMed ID: 14747957
[TBL] [Abstract][Full Text] [Related]
3. Identification of tumour antigens by serological analysis of cDNA expression cloning.
Li G; Miles A; Line A; Rees RC
Cancer Immunol Immunother; 2004 Mar; 53(3):139-43. PubMed ID: 14722670
[TBL] [Abstract][Full Text] [Related]
4. NY-ESO-1 expression and immunogenicity in prostate cancer patients.
Gati A; Lajmi N; Derouiche A; Marrakchi R; Chebil M; Benammar-Elgaaied A
Tunis Med; 2011 Oct; 89(10):779-83. PubMed ID: 22076902
[TBL] [Abstract][Full Text] [Related]
5. Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients.
Mischo A; Wadle A; Wätzig K; Jäger D; Stockert E; Santiago D; Ritter G; Regitz E; Jäger E; Knuth A; Old L; Pfreundschuh M; Renner C
Cancer Immun; 2003 Jun; 3():5. PubMed ID: 12828452
[TBL] [Abstract][Full Text] [Related]
6. Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination.
Kawada J; Wada H; Isobe M; Gnjatic S; Nishikawa H; Jungbluth AA; Okazaki N; Uenaka A; Nakamura Y; Fujiwara S; Mizuno N; Saika T; Ritter E; Yamasaki M; Miyata H; Ritter G; Murphy R; Venhaus R; Pan L; Old LJ; Doki Y; Nakayama E
Int J Cancer; 2012 Feb; 130(3):584-92. PubMed ID: 21413013
[TBL] [Abstract][Full Text] [Related]
7. Identification of human tumor antigens by serological analysis of recombinant cDNA expression libraries (SEREX).
Scanlan MJ
Curr Protoc Immunol; 2005 Mar; Chapter 20():Unit 20.7. PubMed ID: 18432945
[TBL] [Abstract][Full Text] [Related]
8. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening.
Chen YT; Scanlan MJ; Sahin U; Türeci O; Gure AO; Tsang S; Williamson B; Stockert E; Pfreundschuh M; Old LJ
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1914-8. PubMed ID: 9050879
[TBL] [Abstract][Full Text] [Related]
9. NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer.
Nakada T; Noguchi Y; Satoh S; Ono T; Saika T; Kurashige T; Gnjatic S; Ritter G; Chen YT; Stockert E; Nasu Y; Tsushima T; Kumon H; Old LJ; Nakayama E
Cancer Immun; 2003 Jul; 3():10. PubMed ID: 12889868
[TBL] [Abstract][Full Text] [Related]
10. Standard treatments induce antigen-specific immune responses in prostate cancer.
Nesslinger NJ; Sahota RA; Stone B; Johnson K; Chima N; King C; Rasmussen D; Bishop D; Rennie PS; Gleave M; Blood P; Pai H; Ludgate C; Nelson BH
Clin Cancer Res; 2007 Mar; 13(5):1493-502. PubMed ID: 17332294
[TBL] [Abstract][Full Text] [Related]
11. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.
Jäger D; Stockert E; Scanlan MJ; Güre AO; Jäger E; Knuth A; Old LJ; Chen YT
Cancer Res; 1999 Dec; 59(24):6197-204. PubMed ID: 10626813
[TBL] [Abstract][Full Text] [Related]
12. Immunomic analysis of human sarcoma.
Lee SY; Obata Y; Yoshida M; Stockert E; Williamson B; Jungbluth AA; Chen YT; Old LJ; Scanlan MJ
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2651-6. PubMed ID: 12601173
[TBL] [Abstract][Full Text] [Related]
13. The reverse proteomics for identification of tumor antigens.
Lee SY; Jeoung D
J Microbiol Biotechnol; 2007 Jun; 17(6):879-90. PubMed ID: 18050904
[TBL] [Abstract][Full Text] [Related]
14. Identification of lymphoma-associated antigens using SEREX.
Liggins AP; Guinn BA; Banham AH
Methods Mol Med; 2005; 115():109-28. PubMed ID: 15998965
[TBL] [Abstract][Full Text] [Related]
15. [Human esophageal carcinoma antigens screened by serologic analysis of recombinant cDNA expression libraries (SEREX)].
Yu L; Hu H; Ran YL; Peng LP; Li JW; Yang ZH
Ai Zheng; 2007 Jan; 26(1):100-5. PubMed ID: 17222377
[TBL] [Abstract][Full Text] [Related]
16. Immunoscreening of a cDNA library from a lung cancer cell line using autologous patient serum: Identification of XAGE-1b as a dominant antigen and its immunogenicity in lung adenocarcinoma.
Ali Eldib AM; Ono T; Shimono M; Kaneko M; Nakagawa K; Tanaka R; Noguchi Y; Nakayama E
Int J Cancer; 2004 Feb; 108(4):558-63. PubMed ID: 14696120
[TBL] [Abstract][Full Text] [Related]
17. Serological analysis of expression cDNA libraries (SEREX): an immunoscreening technique for identifying immunogenic tumor antigens.
Chen YT; Gure AO; Scanlan MJ
Methods Mol Med; 2005; 103():207-16. PubMed ID: 15542909
[TBL] [Abstract][Full Text] [Related]
18. Immunoscreening of urinary bladder cancer cDNA library and identification of potential tumor antigen.
Chen L; Chen W; Zhao L; Yu HZ; Li X
World J Urol; 2009 Feb; 27(1):107-12. PubMed ID: 18828023
[TBL] [Abstract][Full Text] [Related]
19. Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.
Jäger E; Karbach J; Gnjatic S; Jäger D; Maeurer M; Atmaca A; Arand M; Skipper J; Stockert E; Chen YT; Old LJ; Knuth A
Cancer Immun; 2002 Sep; 2():12. PubMed ID: 12747757
[TBL] [Abstract][Full Text] [Related]
20. Potential target antigens for immunotherapy identified by serological expression cloning (SEREX).
Jäger D
Methods Mol Biol; 2007; 360():319-26. PubMed ID: 17172736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
